HP-001

N/A

Report date: 2026/02/28 20:00:37
NME

Base Information

Drug NameHP-001
Drug Alias NameHP-001HP001
ClassificationSmall molecules > Molecular Glue
Mechanisms of ActionDNA-binding protein Ikaros degradersZinc finger protein Aiolos degraders
TargetsDNA-binding protein IkarosZinc finger protein Aiolos
Therapy Area/IndicationsHematologic NeoplasmsMultiple MyelomaLymphoma, Non-Hodgkin
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesShanghai Helioson Pharmaceutical Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesShanghai Helioson Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsHematologic NeoplasmsMultiple MyelomaLymphoma, Non-Hodgkin
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A